Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BDX
BDX logo

BDX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Becton Dickinson and Co (BDX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
140.710
1 Day change
-2.27%
52 Week Range
213.080
Analysis Updated At
2026/06/18
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Becton Dickinson and Co (BDX) is not a strong buy for a beginner investor with a long-term strategy at this time. The stock exhibits bearish technical indicators, mixed analyst sentiment, and lacks strong positive catalysts. While hedge funds are increasing their positions, the overall sentiment and technical setup do not suggest an immediate buying opportunity.

Technical Analysis

The technical indicators for BDX are bearish. The MACD histogram is negative and expanding downward, the RSI is neutral at 39.807, and the moving averages are aligned in a bearish pattern (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 142.168 and resistance at 146.985.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
11
Buy
4

Positive Catalysts

  • Hedge funds have significantly increased their buying activity, with a 956.90% increase in the last quarter. Congress trading data shows balanced activity with substantial purchase transactions, indicating some level of confidence.

Neutral/Negative Catalysts

  • Analyst sentiment is mixed, with several firms lowering price targets and expressing concerns about inflation, utilization risks, and margin expansion challenges. Technical indicators are bearish, and the stock lacks a clear near-term catalyst for growth.

Financial Performance

Financial data is unavailable for analysis. However, analysts have noted challenges related to inflation, raw material costs, and margin pressures.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is mixed. Price targets range from $159 to $204, with ratings varying from Neutral to Overweight. Concerns about inflation, utilization risks, and headwinds in FY26 and FY27 are prevalent among analysts.

Wall Street analysts forecast BDX stock price to rise
11 Analyst Rating
Wall Street analysts forecast BDX stock price to rise
5 Buy
6 Hold
0 Sell
Moderate Buy
Current: 143.980
sliders
Low
157
Averages
192.64
High
232
Current: 143.980
sliders
Low
157
Averages
192.64
High
232
BofA
Neutral
downgrade
$177 -> $170
AI Analysis
2026-06-12
Reason
BofA
Price Target
$177 -> $170
AI Analysis
2026-06-12
downgrade
Neutral
Reason
BofA lowered the firm's price target on Becton Dickinson to $170 from $177 and keeps a Neutral rating on the shares. Noting that the firm's services team continues to highlight a lower utilization environment, the analyst wants to take a more conservative view on 2027 medtech company estimates given valuations are already reflecting utilization risk, the analyst tells investors. The analyst, who is also assuming inflation is more of a headwind in 2027 with less margin expansion for medtech, lowers 2027 estimates across the firm's larger-cap coverage where there's exposure to utilization and inflation.
Barclays
NULL -> Overweight
maintain
$202 -> $204
2026-05-11
Reason
Barclays
Price Target
$202 -> $204
2026-05-11
maintain
NULL -> Overweight
Reason
Barclays raised the firm's price target on Becton Dickinson to $204 from $202 and keeps an Overweight rating on the shares post the fiscal Q2 report. Becton delivered solid operational growth and upside to consensus estimates, the analyst tells investors in a research note. The firm views the company as well positioned in the current macro environment.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BDX
Unlock Now

People Also Watch